MarketCapExport financials
Option Care Health (OPCH)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Option Care Health Financial Ratios 2025-1997 | OPCH
Brief overview of Option Care Health's financial ratios
The review covers five available annual periods spanning 2021 to 2025.
The latest available valuation ratios are P/E 26.4x (median 26.71x), EV/EBITDA 22.18x (median 23.18x), P/S 0.97x (median 1.22x). The multiple basket looks neutral against its history, differing from median levels by roughly -1.2%.
At the current P/E, inverse earnings yield is 3.8%, a useful bridge between price and business earnings.
The latest available business-quality ratios are ROE 15.7%, ROA 6%, ROCE 12.9%. Fundamental efficiency is balanced: profitability supports valuation but does not remove the need for future growth.
PEG is 1.29x. Price relative to expected growth is in a moderate range.
The cash conversion cycle remains near its former level at 12.9 days after 20.2 days.
Overall picture
Option Care Health's market valuation is near its own historical norm, while quality ratios provide no extreme signal.
Annual Financial Ratios Option Care Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 1997 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
26.4 | 26.7 | 21.8 | 37.9 | 30.0 | -414.1 | -35.8 | -8.9 | -5.5 | -3.0 | -0.4 | -2.7 | -7.9 | 9.9 | 37.3 | -17.4 | 11.9 | -8.6 | 188.9 | - | - |
P/S |
1.0 | 1.1 | 1.4 | 1.4 | 1.2 | 1.1 | 1.2 | 0.6 | 0.4 | 0.1 | 0.1 | 0.4 | 0.7 | 1.0 | 0.2 | 0.7 | 0.5 | 0.5 | 0.5 | - | - |
EPS |
1.3 | 1.2 | 1.5 | 0.8 | 0.8 | -0.0 | -0.5 | -0.5 | -0.6 | -0.6 | -4.5 | -2.1 | -1.1 | 1.1 | 0.1 | -1.4 | 1.4 | -1.9 | 0.1 | - | 1.3 |
EV (Enterprise Value) |
7.38 B | 7.26 B | 7.27 B | 7.14 B | 5.7 B | 4.88 B | 4.33 B | 1.17 B | 1 B | 756 M | 735 M | 1 B | 1.13 B | 926 M | 756 M | 1.66 B | 777 M | 786 M | 626 M | - | - |
EBITDA per Share |
2.5 | 2.23 | 2.09 | 1.66 | 1.41 | 1.01 | 0.342 | 1.28 | 2.14 | 2.38 | 3.05 | 1.24 | 2.4 | 2.88 | 3.78 | 0.26 | 0.53 | -2.06 | 0.35 | - | - |
EV/EBITDA |
18.2 | 19.0 | 19.4 | 23.7 | 22.2 | 24.0 | 73.8 | 23.2 | 12.0 | 10.2 | 10.3 | 38.4 | 25.4 | 19.8 | 11.4 | 128.9 | 37.9 | -9.9 | 48.0 | - | - |
PEG |
1.29 | 0.47 | 0.53 | 1.36 | 1.34 | -41.19 | -0.48 | -0.52 | 0.6 | -0.03 | 0.0 | 0.03 | 0.04 | 0.01 | 0.34 | - | - | - | - | - | - |
P/B |
4.1 | 4.0 | 4.1 | 4.1 | 3.6 | 3.3 | 3.0 | -3.2 | -4.2 | -4.0 | -1.5 | 1.8 | 1.6 | 2.2 | 1.4 | 6.0 | 4.1 | 6.6 | - | - | - |
P/CF |
21.2 | 17.5 | 15.7 | 21.3 | 20.2 | 26.3 | 243.3 | -13.5 | -37.6 | -2.4 | -1.6 | -8.7 | -6.9 | 40.2 | 16.8 | -56.1 | 28.4 | -72.6 | 25.9 | - | - |
ROE % |
15.65 | 15.08 | 18.79 | 10.86 | 11.90 | -0.80 | -8.37 | 35.90 | 75.75 | 131.50 | 370.57 | -68.02 | -19.64 | 22.05 | 3.66 | -34.55 | 34.72 | -77.49 | 2.00 | - | - |
ROA % |
6.01 | 6.19 | 8.30 | 4.84 | 5.01 | -0.31 | -2.93 | -8.85 | -10.64 | -6.83 | -54.84 | -17.88 | -7.43 | 10.07 | 1.16 | -10.41 | 18.84 | -29.98 | - | - | - |
ROCE % |
12.87 | 12.18 | 12.11 | 9.43 | 8.19 | 5.00 | -0.01 | 3.64 | 7.76 | 7.15 | 7.59 | 2.22 | 4.21 | 6.84 | 10.17 | 3.77 | 9.93 | -87.42 | 5.33 | - | - |
Current Ratio |
1.6 | 1.7 | 1.8 | 1.8 | 1.7 | 1.6 | 1.7 | 1.6 | 1.8 | 1.4 | 1.2 | 1.2 | 1.4 | 2.2 | 1.3 | 1.4 | 2.2 | 1.6 | - | - | - |
DSO |
28.5 | 28.8 | 32.0 | 33.1 | 35.4 | 39.3 | 51.3 | 59.1 | 38.2 | 43.6 | 40.3 | 52.2 | 81.2 | 71.1 | 45.3 | 38.4 | 42.5 | 20.7 | - | - | - |
DIO |
34.4 | 35.1 | 32.3 | 29.0 | 23.5 | 21.3 | 23.5 | 20.9 | 25.3 | 19.7 | 21.8 | 18.8 | 22.0 | 28.4 | 13.8 | 79.6 | 15.0 | 6.6 | - | - | - |
DPO |
50.0 | 54.9 | 52.3 | 46.9 | 38.6 | 39.1 | 44.9 | 52.5 | 43.9 | 32.2 | 32.9 | 45.5 | 41.2 | 28.7 | 19.2 | 104.9 | 23.6 | 11.1 | - | - | - |
Operating Cycle |
62.9 | 63.8 | 64.4 | 62.1 | 58.8 | 60.6 | 74.8 | 80.1 | 63.5 | 63.3 | 62.0 | 71.0 | 103.2 | 99.5 | 59.0 | 118.0 | 57.5 | 27.2 | - | - | - |
Cash Conversion Cycle |
12.9 | 8.9 | 12.1 | 15.3 | 20.2 | 21.5 | 29.9 | 27.5 | 19.6 | 31.1 | 29.1 | 25.6 | 62.0 | 70.8 | 39.8 | 13.0 | 34.0 | 16.1 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios Option Care Health
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.29 | 0.32 | 0.31 | 0.28 | - | 0.32 | 0.31 | 0.26 | - | 0.31 | 0.64 | 0.22 | - | 0.21 | 0.19 | 0.17 | - | 0.2 | 0.18 | -0.02 | 0.1 | 0.01 | -0.04 | -0.11 | -0.09 | -0.26 | -0.1 | -0.03 | 0.02 | - | -0.14 | -0.12 | -0.04 | -0.12 | -0.26 | -0.18 | -0.13 | -0.12 | -0.14 | -0.17 | -0.29 | -0.28 | -3.62 | -0.31 | -0.92 | -0.57 | -0.29 | -0.37 | -0.27 | -0.53 | -0.14 | -0.14 | 0.12 | -0.2 | 1.28 | -0.05 | 0.12 | 0.01 | -0.04 | 0.05 | 0.04 | 0.06 | -0.18 | 0.15 |
EBITDA per Share |
0.56 | 0.62 | 0.61 | 0.57 | - | 0.58 | 0.55 | 0.48 | - | 0.54 | 0.54 | 0.45 | - | 0.42 | 0.42 | 0.37 | - | 0.38 | 0.36 | 0.25 | 0.25 | 0.28 | 0.23 | 0.16 | 0.08 | 0.03 | 0.02 | 0.12 | 0.09 | 0.04 | 0.12 | 0.07 | - | 0.17 | 0.12 | 0.06 | - | 0.11 | 0.12 | 0.05 | - | -0.22 | -3.64 | -0.01 | - | -0.34 | -0.04 | -0.11 | - | 0.04 | - | - | - | 0.1 | 0.09 | 0.11 | - | 0.11 | 0.11 | 0.12 | 0.34 | 0.33 | -0.12 | 0.26 |
ROE % |
14.35 | 14.77 | 14.71 | 14.13 | 10.67 | 14.58 | 18.56 | 17.70 | 14.57 | 17.47 | 16.20 | 10.93 | 8.02 | 11.25 | 11.36 | 8.44 | 5.96 | 7.72 | 4.65 | 0.88 | -0.80 | -4.29 | -9.18 | -9.92 | -8.37 | -6.09 | -1.07 | 3.42 | 8.59 | 7.72 | 22.76 | 54.60 | 73.11 | 71.29 | 91.85 | 84.74 | 92.61 | 117.38 | 102.24 | 377.21 | 370.39 | 318.39 | 279.78 | -32.05 | -68.05 | -43.91 | -35.66 | -29.03 | -19.64 | -11.96 | -6.28 | 20.68 | 22.05 | 22.72 | 26.91 | 1.37 | 3.66 | 1.28 | 2.22 | 0.50 | 4.24 | 1.20 | -2.80 | 5.10 |
ROA % |
5.74 | 5.97 | 6.06 | 5.95 | 4.53 | 6.27 | 8.14 | 7.81 | 6.43 | 7.70 | 7.01 | 4.84 | 3.59 | 4.76 | 3.50 | 3.39 | 2.34 | 3.01 | 1.80 | 0.34 | -0.31 | -1.59 | -3.30 | -3.54 | -2.93 | -2.09 | -0.32 | -0.53 | -1.56 | -2.11 | -4.39 | -8.55 | -10.64 | -12.44 | -12.15 | -8.70 | -7.05 | -8.40 | -9.70 | -54.39 | -56.48 | -60.72 | -62.25 | -18.52 | -17.88 | -12.15 | -11.09 | -9.64 | -7.43 | -4.34 | -2.49 | 9.63 | 10.07 | 9.95 | 11.82 | 0.31 | 1.16 | 0.44 | 0.79 | 0.13 | 2.09 | 0.44 | -1.00 | 2.39 |
ROCE % |
12.14 | 12.60 | 12.46 | 11.93 | 8.88 | 11.97 | 11.88 | 11.49 | 8.85 | 11.29 | 12.80 | 11.90 | 9.24 | 11.54 | 11.23 | 7.94 | 5.74 | 7.74 | 7.00 | 5.92 | 5.00 | 3.62 | 1.54 | 0.14 | -0.01 | 0.51 | 2.10 | -3.72 | -6.09 | -3.20 | 19.57 | 339.81 | 341.93 | 341.93 | 341.93 | 341.93 | 341.93 | 341.93 | 341.93 | 349.60 | 345.57 | 332.79 | 305.99 | -13.26 | -20.93 | -21.13 | -9.09 | -6.75 | -1.56 | -0.40 | 0.72 | 2.84 | 3.46 | 5.47 | 6.39 | 7.87 | 6.49 | 11.09 | 14.24 | 9.70 | 13.21 | 5.17 | -2.46 | 5.91 |
Current Ratio |
1.7 | 1.6 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | - | 1.7 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.5 | 1.5 | 1.5 | 1.5 | 1.7 | 1.7 | 0.9 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.0 | 1.0 | 1.0 | 1.0 | 1.4 | 1.4 | 1.4 | 1.4 | 1.6 | 1.6 | 1.6 | 1.6 | 1.8 | 1.8 | 1.8 | 1.8 | 1.5 | 1.5 | 1.5 | 1.5 | 1.6 | 1.6 | 1.6 | 1.9 |
DSO |
33.5 | 30.4 | 30.9 | 30.3 | - | 32.0 | 38.7 | 37.9 | - | 32.5 | 33.8 | 34.7 | - | 16.3 | 17.0 | 35.1 | - | 35.5 | 35.1 | 39.2 | 37.2 | 38.3 | 40.4 | 42.2 | 41.1 | 48.1 | 59.5 | 42.1 | 20.6 | 19.4 | 17.6 | 17.2 | 43.7 | 40.1 | 35.8 | 41.3 | - | - | - | - | - | - | - | - | - | 51.0 | 52.0 | 59.7 | - | 82.4 | 91.2 | 75.9 | - | 72.6 | 75.6 | 103.9 | - | 149.4 | 156.3 | 143.6 | 39.2 | 41.2 | 44.5 | - |
DIO |
34.8 | 32.2 | 30.7 | 32.3 | - | 26.4 | 24.4 | 25.9 | - | 28.0 | 28.6 | 27.5 | - | 13.4 | 13.0 | 25.6 | - | 24.1 | 24.0 | 25.5 | - | 23.8 | 25.2 | 22.9 | - | 22.1 | 83.3 | 74.9 | - | 43.6 | 21.0 | 26.0 | - | 26.3 | 23.1 | 22.1 | - | 20.4 | 19.6 | 20.7 | - | 21.6 | 21.5 | 20.4 | - | 19.9 | 18.7 | 18.7 | - | 24.3 | 27.4 | 24.9 | - | 27.6 | 30.2 | 23.2 | - | 20.5 | 20.6 | 48.4 | 15.0 | 15.4 | 16.7 | - |
DPO |
49.2 | 47.8 | 44.5 | 48.6 | - | 50.4 | 47.7 | 45.9 | - | 48.8 | 51.1 | 48.0 | - | 23.3 | 21.3 | 40.5 | - | 41.6 | 41.4 | 44.1 | - | 42.5 | 44.9 | 42.0 | - | 42.2 | 159.0 | 153.8 | - | 101.1 | 52.8 | 53.4 | - | 45.5 | 40.0 | 38.9 | - | 33.3 | 32.1 | 32.5 | - | 32.6 | 32.6 | 39.2 | - | 47.9 | 45.2 | 40.2 | - | 45.0 | 50.6 | 35.7 | - | 28.0 | 30.6 | 50.8 | - | 90.1 | 90.6 | 94.1 | 19.5 | 20.6 | 22.3 | - |
Operating Cycle |
- | - | 61.6 | 62.6 | - | 58.5 | 63.2 | 63.8 | - | 60.5 | 62.4 | 62.2 | - | 29.7 | 30.0 | 60.6 | - | 59.6 | 59.1 | 64.7 | 37.2 | 62.1 | 65.6 | 65.1 | 41.1 | 70.2 | 142.9 | 117.0 | 20.6 | 63.1 | 38.6 | 43.2 | 43.7 | 66.4 | 58.9 | 63.5 | - | 20.4 | 19.6 | 20.7 | - | 21.6 | 21.5 | 20.4 | - | 70.8 | 70.7 | 78.4 | - | 106.7 | 118.5 | 100.8 | - | 100.3 | 105.8 | 127.2 | - | 169.9 | 176.9 | - | - | - | - | - |
Cash Conversion Cycle |
- | - | 17.1 | 14.0 | - | 8.1 | 15.5 | 17.9 | - | 11.7 | 11.3 | 14.2 | - | 6.4 | 8.7 | 20.1 | - | 18.0 | 17.7 | 20.6 | 37.2 | 19.6 | 20.7 | 23.1 | 41.1 | 28.0 | -16.1 | -36.8 | 20.6 | -38.0 | -14.2 | -10.2 | 43.7 | 20.8 | 18.9 | 24.6 | - | -12.9 | -12.4 | -11.8 | - | -11.1 | -11.1 | -18.8 | - | 22.9 | 25.5 | 38.2 | - | 61.7 | 67.9 | 65.1 | - | 72.3 | 75.2 | 76.4 | - | 79.8 | 86.3 | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company Option Care Health, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
China
USA
Russia
Germany
Britain
